UNLIKE PFIZER VACCINE, FDA TAKES A YEAR TO APPROVE EMPAGLIFLOZIN FOR PATIENTS WITH HEART FAILURE

First published at 09:58 UTC on August 24th, 2021.

CategoryEducation
SensitivityNormal - Content that is suitable for ages 16 and over